Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms FB 6001, FB6001 |
Target |
Mechanism PCSK9 modulators(Proprotein convertase subtilisin kexin type 9 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperlipidemias | Phase 1 | - | 31 Aug 2022 | |
Cardiovascular Diseases | Preclinical | CN | 31 Aug 2022 | |
Heterozygous familial hypercholesterolemia | Preclinical | CN | 31 Aug 2022 | |
Hyperlipidemia, Familial Combined | Preclinical | CN | 31 Aug 2022 |